Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1994 1
1999 1
2000 1
2001 1
2002 2
2003 1
2004 4
2005 4
2006 5
2007 2
2008 3
2009 2
2010 3
2011 6
2012 4
2013 6
2014 5
2015 3
2016 4
2017 1
2018 7
2019 7
2020 7
2021 8
2022 9
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

90 results

Results by year

Filters applied: . Clear all
Page 1
Semaglutide and effective weight control.
Latini R, Staszewsky L. Latini R, et al. Among authors: staszewsky l. Lancet. 2021 Mar 13;397(10278):942-943. doi: 10.1016/S0140-6736(21)00377-9. Epub 2021 Mar 2. Lancet. 2021. PMID: 33667415 No abstract available.
What is the atrium trying to tell us?
Staszewsky L, Latini R. Staszewsky L, et al. Eur Heart J. 2013 Jan;34(4):255-7. doi: 10.1093/eurheartj/ehs327. Epub 2012 Oct 22. Eur Heart J. 2013. PMID: 23091200 No abstract available.
Searching for Preclinical Models of Acute Decompensated Heart Failure: a Concise Narrative Overview and a Novel Swine Model.
Olivari D, De Giorgio D, Staszewsky LI, Fumagalli F, Boccardo A, Novelli D, Manfredi M, Babini G, Luciani A, Ruggeri L, Magliocca A, Zani DD, Masson S, Belloli A, Pravettoni D, Maiocchi G, Latini R, Ristagno G. Olivari D, et al. Among authors: staszewsky li. Cardiovasc Drugs Ther. 2022 Aug;36(4):727-738. doi: 10.1007/s10557-020-07096-5. Epub 2020 Oct 24. Cardiovasc Drugs Ther. 2022. PMID: 33098053 Free PMC article. Review.
Rationale and design of the pragmatic clinical trial tREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fracTion (REBOOT).
Rossello X, Raposeiras-Roubin S, Latini R, Dominguez-Rodriguez A, Barrabés JA, Sánchez PL, Anguita M, Fernández-Vázquez F, Pascual-Figal D, De la Torre Hernandez JM, Ferraro S, Vetrano A, Pérez-Rivera JA, Prada-Delgado O, Escalera N, Staszewsky L, Pizarro G, Agüero J, Pocock S, Ottani F, Fuster V, Ibáñez B; REBOOT-CNIC investigators. Rossello X, et al. Among authors: staszewsky l. Eur Heart J Cardiovasc Pharmacother. 2022 May 5;8(3):291-301. doi: 10.1093/ehjcvp/pvab060. Eur Heart J Cardiovasc Pharmacother. 2022. PMID: 34351426 Clinical Trial.
Murine models of myocardial and limb ischemia: diagnostic end-points and relevance to clinical problems.
Madeddu P, Emanueli C, Spillmann F, Meloni M, Bouby N, Richer C, Alhenc-Gelas F, Van Weel V, Eefting D, Quax PH, Hu Y, Xu Q, Hemdahl AL, van Golde J, Huijberts M, de Lussanet Q, Struijker Boudier H, Couffinhal T, Duplaa C, Chimenti S, Staszewsky L, Latini R, Baumans V, Levy BI. Madeddu P, et al. Among authors: staszewsky l. Vascul Pharmacol. 2006 Nov;45(5):281-301. doi: 10.1016/j.vph.2006.08.008. Epub 2006 Aug 22. Vascul Pharmacol. 2006. PMID: 17010676 Review.
Valsartan for the treatment of heart failure.
Latini R, Masson S, Staszewsky L, Maggioni AP. Latini R, et al. Among authors: staszewsky l. Expert Opin Pharmacother. 2004 Jan;5(1):181-93. doi: 10.1517/14656566.5.1.181. Expert Opin Pharmacother. 2004. PMID: 14680446 Review.
Total NT-proBNP, a novel biomarker related to recurrent atrial fibrillation.
Staszewsky L, Meessen JMTA, Novelli D, Wienhues-Thelen UH, Disertori M, Maggioni AP, Masson S, Tognoni G, Franzosi MG, Lucci D, Latini R. Staszewsky L, et al. BMC Cardiovasc Disord. 2021 Nov 19;21(1):553. doi: 10.1186/s12872-021-02358-y. BMC Cardiovasc Disord. 2021. PMID: 34798808 Free PMC article. Clinical Trial.
90 results